Foster & Motley Inc. Reduces Stock Position in The Procter & Gamble Company (NYSE:PG)

Foster & Motley Inc. cut its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 1.1% in the second quarter, Holdings Channel.com reports. The firm owned 73,489 shares of the company’s stock after selling 791 shares during the quarter. Procter & Gamble makes up approximately 0.8% of Foster & Motley Inc.’s investment portfolio, making the stock its 22nd biggest position. Foster & Motley Inc.’s holdings in Procter & Gamble were worth $12,120,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the stock. Advantage Trust Co purchased a new position in Procter & Gamble in the fourth quarter worth approximately $28,000. Transcendent Capital Group LLC purchased a new position in Procter & Gamble in the fourth quarter worth approximately $31,000. Ruedi Wealth Management Inc. grew its position in Procter & Gamble by 64.7% in the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after acquiring an additional 77 shares during the period. POM Investment Strategies LLC purchased a new position in Procter & Gamble in the second quarter worth approximately $34,000. Finally, Vima LLC purchased a new position in Procter & Gamble in the fourth quarter worth approximately $35,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Procter & Gamble news, CEO R. Alexandra Keith sold 3,373 shares of the firm’s stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $170.00, for a total transaction of $573,410.00. Following the transaction, the chief executive officer now owns 21,513 shares of the company’s stock, valued at $3,657,210. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, CEO R. Alexandra Keith sold 3,373 shares of the firm’s stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $170.00, for a total transaction of $573,410.00. Following the transaction, the chief executive officer now owns 21,513 shares of the company’s stock, valued at $3,657,210. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Andre Schulten sold 13,041 shares of the firm’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the transaction, the chief financial officer now directly owns 37,208 shares in the company, valued at approximately $6,325,360. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 375,553 shares of company stock valued at $63,829,141. 0.17% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

PG has been the subject of several analyst reports. Dbs Bank lowered Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. BNP Paribas started coverage on Procter & Gamble in a research report on Monday, June 24th. They set an “outperform” rating and a $187.00 price target for the company. Deutsche Bank Aktiengesellschaft raised their price target on Procter & Gamble from $171.00 to $176.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Barclays lowered their price target on Procter & Gamble from $174.00 to $163.00 and set an “overweight” rating for the company in a research report on Thursday, August 1st. Finally, StockNews.com lowered Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Eight research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and an average target price of $175.79.

Read Our Latest Research Report on Procter & Gamble

Procter & Gamble Stock Up 0.1 %

Procter & Gamble stock traded up $0.10 during midday trading on Thursday, reaching $176.00. The company’s stock had a trading volume of 734,225 shares, compared to its average volume of 6,564,774. The Procter & Gamble Company has a fifty-two week low of $141.45 and a fifty-two week high of $176.50. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The company has a market cap of $415.38 billion, a P/E ratio of 28.75, a P/E/G ratio of 3.72 and a beta of 0.41. The business has a 50-day simple moving average of $167.87 and a 200-day simple moving average of $164.45.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The company had revenue of $20.53 billion for the quarter, compared to analysts’ expectations of $20.69 billion. During the same period last year, the firm earned $1.37 earnings per share. Procter & Gamble’s quarterly revenue was down .1% on a year-over-year basis. On average, research analysts expect that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were issued a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.29%. The ex-dividend date was Friday, July 19th. Procter & Gamble’s payout ratio is 65.85%.

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Further Reading

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.